Eloxx Pharmaceuticals Inc (ELOX)
0.81
-0.02
(-1.82%)
USD |
OTCM |
Apr 24, 16:00
Eloxx Pharmaceuticals Net Income (TTM): -20.48M for Sept. 30, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -20.48M |
| June 30, 2023 | -24.40M |
| March 31, 2023 | -30.68M |
| December 31, 2022 | -36.06M |
| September 30, 2022 | -41.84M |
| June 30, 2022 | -44.21M |
| March 31, 2022 | -69.65M |
| December 31, 2021 | -66.73M |
| September 30, 2021 | -60.76M |
| June 30, 2021 | -57.50M |
| March 31, 2021 | -29.32M |
| December 31, 2020 | -34.58M |
| September 30, 2020 | -40.08M |
| June 30, 2020 | -46.34M |
| March 31, 2020 | -52.90M |
| December 31, 2019 | -50.87M |
| September 30, 2019 | -53.27M |
| June 30, 2019 | -51.55M |
| March 31, 2019 | -50.51M |
| December 31, 2018 | -47.18M |
| September 30, 2018 | -34.42M |
| June 30, 2018 | -25.27M |
| March 31, 2018 | -13.93M |
| September 30, 2017 | -6.130M |
| June 30, 2017 | -5.796M |
| Date | Value |
|---|---|
| March 31, 2017 | -4.942M |
| December 31, 2016 | -5.955M |
| September 30, 2016 | -9.021M |
| June 30, 2016 | -8.268M |
| March 31, 2016 | -8.022M |
| December 31, 2015 | -6.17M |
| September 30, 2015 | -13.06M |
| June 30, 2015 | -18.06M |
| March 31, 2015 | -20.83M |
| December 31, 2014 | -21.75M |
| September 30, 2014 | -12.62M |
| June 30, 2014 | -9.225M |
| March 31, 2014 | -7.481M |
| December 31, 2013 | -6.171M |
| September 30, 2013 | -5.821M |
| June 30, 2013 | -6.122M |
| March 31, 2013 | -5.631M |
| December 31, 2012 | -5.855M |
| September 30, 2012 | -6.113M |
| June 30, 2012 | -5.066M |
| March 31, 2012 | -6.339M |
| December 31, 2011 | -6.684M |
| September 30, 2011 | -6.292M |
| June 30, 2011 | -7.269M |
| March 31, 2011 | -10.76M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-69.65M
Minimum
Mar 2022
-20.48M
Maximum
Sep 2023
-45.07M
Average
-45.28M
Median
Net Income (TTM) Benchmarks
| NovaBay Pharmaceuticals Inc | -9.64M |
| Palatin Technologies Inc | -31.59M |
| iBio Inc | -27.28M |
| Theriva Biologics Inc | -18.35M |
| Oragenics Inc | -20.66M |